Clinuvel Pharmaceuticals (UR9.F) Q1 2021 Earnings

24FebConfirmed
Q1 2021
0.09
0.1
0.12
0.14

Details

Expected EPS
0.14422690282431785
Actual EPS
0.08522498803255145
Surprise EPS
-0.06
Surprise Percent
+40.91%

Description

Clinuvel Pharmaceuticals (UR9.F) has reported earnings of 0.08522498803255145 per share for Q1 2021.

0 Comments

Share your thoughts